Skip to main content
Journal cover image

Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.

Publication ,  Journal Article
Kim, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, M-J; Jung, S-H
Published in: Eur Radiol
August 2017

OBJECTIVES: Characteristics of hepatocellular carcinoma (HCC) on magnetic resonance (MR) images were compared in patients who did or did not undergo liver transplantation (LT), and we evaluated the relationship of these findings with overall survival (OS) and time-to-tumour recurrence (TTR) after transplantation. METHODS: The enhancement pattern of gadoxetic acid-enhanced MR images of 25 patients with recurrent HCCs (LT group) and 25 surgically confirmed HCC patients in the non-transplanted (control) group were compared. Typical enhancement was defined as 1) arterial enhancement and delayed wash-out and 2) absence of typical features of cholangiocarcinoma consisting of arterial rim enhancement and target appearance on hepatobiliary phase images. OS and TTR were analyzed in the LT group according to these patterns using the log-rank test. RESULTS: HCCs in the LT group significantly more often had an atypical enhancement pattern (16/25, 64.0%) than those in the control group (5/25, 20.0%; p = 0.004). However, OS and TTR did not differ significantly according to these enhancement patterns of recurrent HCC (p > 0.05). CONCLUSION: Although enhancement patterns of recurrent HCC in transplanted liver did not affect OS and TTR, these HCCs that arise after LT frequently revealed atypical enhancement on gadoxetic acid-enhanced MR imaging. KEY POINTS: • Recurrent HCCs after LT showed atypical enhancement on gadoxetic acid-enhanced MRI. •They showed absence of delayed wash-out or cholangiocarinoma-like features. • Enhancement patterns of recurrent HCCs did not affect OS and TTR.

Duke Scholars

Published In

Eur Radiol

DOI

EISSN

1432-1084

Publication Date

August 2017

Volume

27

Issue

8

Start / End Page

3117 / 3127

Location

Germany

Related Subject Headings

  • Retrospective Studies
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Liver Transplantation
  • Liver Neoplasms
  • Humans
  • Gadolinium DTPA
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, M., Kang, T. W., Jeong, W. K., Kim, Y. K., Kim, S. H., Kim, J. M., … Jung, S.-H. (2017). Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. Eur Radiol, 27(8), 3117–3127. https://doi.org/10.1007/s00330-016-4662-2
Kim, Mimi, Tae Wook Kang, Woo Kyoung Jeong, Young Kon Kim, Seong Hyun Kim, Jong Man Kim, Dong Hyun Sinn, Min-Ji Kim, and Sin-Ho Jung. “Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.Eur Radiol 27, no. 8 (August 2017): 3117–27. https://doi.org/10.1007/s00330-016-4662-2.
Kim M, Kang TW, Jeong WK, Kim YK, Kim SH, Kim JM, et al. Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. Eur Radiol. 2017 Aug;27(8):3117–27.
Kim, Mimi, et al. “Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.Eur Radiol, vol. 27, no. 8, Aug. 2017, pp. 3117–27. Pubmed, doi:10.1007/s00330-016-4662-2.
Kim M, Kang TW, Jeong WK, Kim YK, Kim SH, Kim JM, Sinn DH, Kim M-J, Jung S-H. Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. Eur Radiol. 2017 Aug;27(8):3117–3127.
Journal cover image

Published In

Eur Radiol

DOI

EISSN

1432-1084

Publication Date

August 2017

Volume

27

Issue

8

Start / End Page

3117 / 3127

Location

Germany

Related Subject Headings

  • Retrospective Studies
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Recurrence, Local
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Liver Transplantation
  • Liver Neoplasms
  • Humans
  • Gadolinium DTPA